-
EP1436310
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1436310
| EP1436310 - ANTISENSE MODULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 EXPRESSION [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 18.02.2005 Database last updated on 13.11.2024 | Most recent event Tooltip | 13.11.2009 | Change - representative | published on 16.12.2009 [2009/51] | Applicant(s) | For all designated states Isis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad, CA 92010 / US | [N/P] |
| Former [2004/29] | For all designated states ISIS PHARMACEUTICALS, INC. 2292 Faraday Avenue Carlsbad, CA 92008 / US | Inventor(s) | 01 /
BENNETT, C., Frank 1347 Cassing Street Carlsbad, CA 92008 / US | 02 /
WATT, Andrew, T. 1500 Shadowridge Drive Apartment 154 Vista, CA 92083 / US | [2004/29] | Representative(s) | Hallybone, Huw George, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
| Former [2009/51] | Hallybone, Huw George, et al Carpmaels & Ransford 43-45 Bloomsbury Square London WC1A 2RA / GB | ||
| Former [2004/29] | Hallybone, Huw George, et al Carpmaels and Ransford, 43-45 Bloomsbury Square London WC1A 2RA / GB | Application number, filing date | 02763756.0 | 26.09.2002 | [2004/29] | WO2002US30734 | Priority number, date | US20010967655 | 28.09.2001 Original published format: US 967655 | [2004/29] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO03029266 | Date: | 10.04.2003 | Language: | EN | [2003/15] | Type: | A1 Application with search report | No.: | EP1436310 | Date: | 14.07.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.04.2003 takes the place of the publication of the European patent application. | [2004/29] | Search report(s) | International search report - published on: | US | 10.04.2003 | Classification | IPC: | C07H21/04, C07H21/02, A61K48/00, C12Q1/68, C12N15/85, C12N15/86, C12P19/34, C12N15/11 | [2005/13] | CPC: |
C12N15/1138 (EP,US);
A61K38/00 (EP,US);
C12N2310/315 (EP,US);
C12N2310/321 (EP,US);
C12N2310/3341 (EP,US);
C12N2310/341 (EP,US);
| C-Set: |
C12N2310/321, C12N2310/3525 (EP,US)
|
| Former IPC [2004/29] | C07H21/04, C07H21/02, A61K48/00, C12Q1/68, C12N15/85, C12N15/86, C12P19/34 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SK, TR [2004/29] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | ANTISENSE-MODULATION DES VASKULÄREN ENDOTHELWACHSTUMSFAKTOR REZEPTORS 2 | [2004/29] | English: | ANTISENSE MODULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 EXPRESSION | [2004/29] | French: | MODULATION ANTISENS DE L'EXPRESSION DU RECEPTEUR 2 DU FACTEUR DE CROISSANCE DE L'ENDOTHELIUM VASCULAIRE | [2004/29] | Entry into regional phase | 22.04.2004 | National basic fee paid | 22.04.2004 | Search fee paid | 22.04.2004 | Designation fee(s) paid | 22.04.2004 | Examination fee paid | Examination procedure | 16.04.2003 | Request for preliminary examination filed International Preliminary Examining Authority: US | 22.04.2004 | Amendment by applicant (claims and/or description) | 22.04.2004 | Examination requested [2004/29] | 09.02.2005 | Application withdrawn by applicant [2005/14] | Fees paid | Renewal fee | 22.04.2004 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]US5801154 (BARACCHINI EDGARDO [US], et al); | [A]US6346398 (PAVCO PAMELA [US], et al); | [X] - PARRY ET AL., "Bioactivity of anti-angiogenic ribozymes targeting Flt-1 and KDR mRNA", NUCLEIC ACIDS RESEARCH, (199905), vol. 27, no. 13, pages 2569 - 2577, XP002971041 DOI: http://dx.doi.org/10.1093/nar/27.13.2569 | [X] - PAVCO ET AL., "Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors", CLINICAL CANCER RESEARCH, (200005), vol. 6, pages 2094 - 2103, XP002971042 | [X] - HENDERSON ET AL., "The basic-helix-loop-helix transcription factor HESR1 regulates endothelial cell tube formation", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (20010302), vol. 276, no. 9, pages 6169 - 6176, XP002971043 DOI: http://dx.doi.org/10.1074/jbc.M008506200 | [X] - BERNATCHEZ ET AL., "Vascular endothelial growth factor effect on endothelial cell proliferation, migration and platelet-activating factor synthesis is Flk-1-dependent", JOURNAL OF BIOLOGICAL CHEMISTRY, (19991022), vol. 274, no. 43, pages 31047 - 31054, XP002971044 DOI: http://dx.doi.org/10.1074/jbc.274.43.31047 | [X] - BERARD ET AL., "Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas", AMERICAN JOURNAL OF PATHOLOGY, (199704), vol. 150, no. 4, pages 1315 - 1326, XP002971045 | [Y] - MILNER ET AL., "Selecting effective antisense reagents on combinatorial oligonucleotide arrays", NATURE BIOTECHNOLOGY, (199706), vol. 15, pages 537 - 541, XP002971046 DOI: http://dx.doi.org/10.1038/nbt0697-537 |